Table 3. Treatment-related adverse events occurring in >5% of patients.
Adverse event, n (%) | Patients (N = 146) |
---|---|
Fatigue | 50 (34.2) |
Nausea | 43 (29.5) |
Hyperglycemia | 35 (24.0) |
Decreased appetite | 34 (23.3) |
Diarrhea | 33 (22.6) |
Aspartate aminotransferase increased | 25 (17.1) |
Vomiting | 23 (15.8) |
Depression | 22 (15.1) |
Alanine aminotransferase increased | 21 (14.4) |
Anxiety | 20 (13.7) |
Rash | 20 (13.7) |
Weight decreased | 15 (10.3) |
Dysgeusia | 11 (7.5) |
Dyspepsia | 10 (6.8) |
Mucosal inflammation | 10 (6.8) |
Insomnia | 9 (6.2) |